Filing Details

Accession Number:
0001237899-12-000088
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-27 18:23:45
Reporting Period:
2012-11-23
Filing Date:
2012-11-27
Accepted Time:
2012-11-27 18:23:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1013064 Roy P Vagelos 777 Old Saw Mill River Road
Tarrytown NY 10591
Chairman Of The Board Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-11-23 312,500 $19.43 369,446 No 4 M Direct
Common Stock Disposition 2012-11-23 34,696 $175.00 334,750 No 4 F Direct
Common Stock Disposition 2012-11-23 127,417 $175.00 207,333 No 4 F Direct
Common Stock Disposition 2012-11-26 28,507 $175.12 178,826 No 4 S Direct
Common Stock Disposition 2012-11-27 32,356 $175.19 146,470 No 4 S Direct
Common Stock Disposition 2012-11-27 3,890 $176.18 142,580 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-11-23 312,500 $0.00 312,500 $19.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-12-20 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 82,410 Indirect by GRAT
Common Stock 2,329 Indirect By 401(k) Plan
Common Stock 162,657 Indirect by CLAT
Common Stock 15,162 Indirect by GRAT
Common Stock 3 Indirect by GRAT
Common Stock 127,500 Indirect by Spouse as Trustee
Common Stock 1,203 Indirect by trust for grandch
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 28,507 shares of Company stock on November 26, 2012 at prices ranging from $175.00 to $175.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price.
  3. Represents volume-weighted average price of sales of 32,356 shares of Company stock on November 27, 2012 at prices ranging from $175.00 to $175.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 27, 2012 at each separate price.
  4. Represents volume-weighted average price of sales of 3,890 shares of Company stock on November 27, 2012 at prices ranging from $176.00 to $176.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 27, 2012 at each separate price.
  5. By an irrevocable trust for the benefit of grandchildren of the reporting person, of which the spouse of the reporting person is trustee.
  6. By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.
  7. The stock option becomes exercisable in two equal annual installments, commencing one year after the date of grant.
  8. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.